SMCHD1 and facioscapulohumeral muscular dystrophy: We first performed optical genome mapping with EnFocusTM FSHD analysis using DLE-1 labeling and the Saphyr instrument in patients with inconclusive diagnostic Southern blot results, negative FSHD2 results, and clinically evident FSHD.